Aller au contenu principal
Profil bibliographique

Minoru Nakazono

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

25Publications signalées
89Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Bladder and Urothelial Cancer TreatmentsProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchRenal cell carcinoma treatmentUrinary and Genital Oncology Studies

Les publications récentes

2026 article OpenAlex

Stage-specific prognostic impact and recurrence patterns according to tumor location in upper tract urothelial carcinoma following radical nephroureterectomy: a propensity score-matched analysis

Yue Ogihara, Fumihiko Urabe, Masataka Kubo, Naoki Uchida et autres

BACKGROUND: The prognostic significance of the location of the primary tumor in upper tract urothelial carcinoma (UTUC) remains controversial. We evaluated the impact of ureteral urothelial carcinoma (UUC) versus renal pelvic urothelial carcinoma (RPUC) on oncological outcomes and recurrence patterns following radical …

jp (code pays fourni par la source)

0 citations Japanese Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Laparoscopic Ureteral Substitution Using the Appendix for Complete Stenosis of the Middle Ureter due to Ureteral Stone in an Elderly Patient: A Case Report

Ryutaro Fukagai, Shuichi Shimabukuro, Masafumi Ie, Minoru Nakazono et autres

Introduction: While established in pediatric urology, the laparoscopic use of appendiceal substitution of the ureter in adults is rare. Case Presentation: An 83-year-old man developed a 2.5-cm right mid-ureteral stricture as a complication after endoscopic treatment for a ureteral stone. Preoperative imaging …

jp (code pays fourni par la source)

0 citations IJU Case Reports
Accès ouvert 2025 article OpenAlex

Retroperitoneal Laparoscopic Right Heminephrectomy for Renal Cell Carcinoma in a Horseshoe Kidney

Yasuhiro Andoh, Atsuhiko Ochi, Hidetsugu Takahashi, Minoru Nakazono et autres

Introduction: Laparoscopic heminephrectomy for renal cell carcinoma in horseshoe kidneys has been previously reported, but reports on the retroperitoneal approach remain limited. This paper presents a case demonstrating the feasibility and effectiveness of this surgical technique. Case Presentation: A 74-year-old woman was …

jp (code pays fourni par la source)

0 citations IJU Case Reports
Accès ouvert 2025 article OpenAlex

Vaginal Laser Therapy as a Potential Treatment Option for Postmenopausal Women With Recurrent Cystitis: Initial Experience From a Single Institution

Hirokazu Abe, Fumihiko Urabe, Minoru Nakazono, Ayaka Kawaharada et autres

BACKGROUND: Recurrent cystitis is a prevalent condition, especially among postmenopausal women, significantly impairing their quality of life. Antibiotic therapy has historically been the primary treatment; however, concerns over antimicrobial resistance have highlighted the need for alternative therapies. Vaginal laser therapy, a noninvasive …

jp, us (code pays fourni par la source)

0 citations Lasers in Surgery and Medicine
2025 article OpenAlex

Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First‐Line Platinum‐Based Chemotherapy: A Multicenter Collaborative Study

Fumihiko Urabe, Kojiro Tashiro, Yu Imai, Kosuke Iwatani et autres

BACKGROUND: Few studies have provided a comprehensive analysis of sequential treatment strategies for locally advanced and metastatic urothelial carcinoma (la/mUC). This study assessed treatment patterns, prognostic factors, and optimal sequencing strategies in patients receiving first-line platinum-based chemotherapy (1 L-PBC). METHODS: This retrospective, …

jp (code pays fourni par la source)

5 citations International Journal of Urology
2025 article OpenAlex

Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study

Fumihiko Urabe, Naoki Uchida, Hirokazu Kagawa, Katsuki Muramoto et autres

BACKGROUND: Despite advancements in treatment options for metastatic urothelial carcinoma (mUC), therapeutic choices remain limited for patients with disease refractory to platinum-based chemotherapy (PBC) and immune checkpoint inhibitors (ICIs). Enfortumab vedotin (EV) has demonstrated significant efficacy in later lines of therapy for …

jp (code pays fourni par la source)

6 citations Japanese Journal of Clinical Oncology
2025 article OpenAlex

Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative study

Fumihiko Urabe, Naoki Uchida, Soshi Kadena, Ken Shibata et autres

BACKGROUND: The JAVELIN Bladder 100 trial demonstrated improved overall survival (OS) with maintenance avelumab in patients with locally advanced or metastatic urothelial carcinoma UC (la/mUC) who achieved disease control following first-line platinum-based chemotherapy (1 L-PBC). However, real-world data on eligibility, utilization, and …

jp (code pays fourni par la source)

2 citations Japanese Journal of Clinical Oncology
Accès ouvert 2024 article OpenAlex

Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective study

Naoki Uchida, Fumihiko Urabe, Yushi Suhara, Yuma Goto et autres

Background: An earlier systematic review and meta-analysis found that patients with a certain histological variant of upper tract urothelial carcinoma (UTUC) exhibited more advanced disease and poorer survival than those with pure UTUC. A difference in the clinicopathological UTUC characteristics of Caucasian …

jp (code pays fourni par la source)

5 citations Translational Andrology and Urology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.